Anti-PCV3 Cap/Capsid Polyclonal Antibody from ProteoGenix; catalogue ARO-A22500; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-PCV3 Cap/Capsid Polyclonal Antibody
The Anti-PCV3 Cap/Capsid Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection and quantification of Porcine Circovirus Type 3 (PCV3) in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the capsid protein of PCV3, resulting in a high affinity and specificity for the target antigen.
PCV3 is a small, non-enveloped virus that belongs to the Circoviridae family. It is known to cause a wide range of clinical symptoms in pigs, including respiratory and reproductive disorders, as well as systemic and neurological diseases. The capsid protein of PCV3 is essential for viral replication and is a key target for diagnostic and research purposes. The Anti-PCV3 Cap/Capsid Polyclonal Antibody binds specifically to this protein, making it an ideal tool for studying the virus and its pathogenicity.
This antibody has been extensively validated for use in various applications, including ELISA, Western blotting, and immunohistochemistry. It is suitable for both qualitative and quantitative detection of PCV3 in serum, tissue, and other biological samples. The high specificity and sensitivity of this antibody make it an essential tool for diagnostic laboratories, research institutions, and biotech companies working on PCV3-related projects.
The Anti-PCV3 Cap/Capsid Polyclonal Antibody has been successfully used in several experimental studies to detect and quantify PCV3 in different sample types. In a recent study, this antibody was used to detect PCV3 in serum samples from pigs with clinical signs of the disease, showing a high correlation with PCR results. In another study, the antibody was used to detect viral antigens in lung tissue samples from pigs with respiratory symptoms, providing valuable insights into the pathogenesis of PCV3.
In conclusion, the Anti-PCV3 Cap/Capsid Polyclonal Antibody is a highly reliable and specific tool for the detection and quantification of PCV3 in various sample types. Its use in multiple applications and successful experimental studies make it a valuable asset for researchers and diagnosticians working on PCV3-related projects. Order now and enhance your PCV3 research with this high-quality antibody.
ProteoGenix catalogue number ARO-A22500. For research use only.
Target: Cap, Capsid, cap, Cap, ORF2; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Cap, Capsid, cap, Cap, ORF2 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
